EMA Withdrawn: Onsenal (celecoxib) — Pfizer Limited

View source ↗

Summary

The EMA has withdrawn Onsenal (celecoxib) from consideration/market in 2011 under Pfizer Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomatous Polyposis Coli

Drugs mentioned

• Onsenal (celecoxib)

Snippet

Status: Withdrawn. Therapeutic area: Adenomatous Polyposis Coli. MAH: Pfizer Limited. Decision date: 28/03/2011